One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis

Conditions: Fascioliasis Interventions: Drug: Oxfendazole; Drug: Triclabendazole Sponsors: Universidad Peruana Cayetano Heredia; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials